Option Care Health, Inc. (NASDAQ:OPCH) Stock Position Lifted by Diversify Wealth Management LLC

Diversify Wealth Management LLC grew its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 15.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,299 shares of the company’s stock after buying an additional 1,364 shares during the period. Diversify Wealth Management LLC’s holdings in Option Care Health were worth $309,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. UMB Bank n.a. raised its position in shares of Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC raised its position in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. raised its position in shares of Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares during the period. SageView Advisory Group LLC acquired a new stake in shares of Option Care Health during the 1st quarter worth approximately $85,000. Finally, International Assets Investment Management LLC raised its position in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares during the period. Institutional investors own 98.05% of the company’s stock.

Insiders Place Their Bets

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

Shares of OPCH stock opened at $24.11 on Friday. Option Care Health, Inc. has a 1-year low of $22.84 and a 1-year high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.36 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $4.12 billion, a price-to-earnings ratio of 20.26, a P/E/G ratio of 1.79 and a beta of 1.29. The stock’s fifty day simple moving average is $30.49 and its 200-day simple moving average is $29.92.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. On average, sell-side analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently commented on the company. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the company from $43.00 to $29.00 in a research report on Wednesday. Truist Financial lowered their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the company from $38.00 to $26.00 in a research note on Thursday. JMP Securities increased their price target on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Finally, Barrington Research decreased their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $31.60.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.